BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32109311)

  • 1. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
    Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
    Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
    J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
    Visonneau S; Cesano A; Torosian MH; Miller EJ; Santoli D
    Am J Pathol; 1998 May; 152(5):1299-311. PubMed ID: 9588898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
    Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
    Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation.
    Zhang Y; Zhang GL; Sun X; Cao KX; Ma C; Nan N; Yang GW; Yu MW; Wang XM
    Oncol Lett; 2018 May; 15(5):6233-6240. PubMed ID: 29616105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
    Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
    J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
    Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
    Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
    Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
    Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers.
    Moon HG; Oh K; Lee J; Lee M; Kim JY; Yoo TK; Seo MW; Park AK; Ryu HS; Jung EJ; Kim N; Jeong S; Han W; Lee DS; Noh DY
    Breast Cancer Res Treat; 2015 Nov; 154(1):13-22. PubMed ID: 26438141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
    Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
    J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts.
    Leiting JL; Hernandez MC; Yang L; Bergquist JR; Ivanics T; Graham RP; Truty MJ
    Sci Rep; 2019 Apr; 9(1):5901. PubMed ID: 30976061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.